ClinicalTrials.Veeva
Menu

Find clinical trials for Pancreatic Cancer in Birmingham, AL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Adenocarcinoma
Cancer
Carcinoma
Colorectal Cancer
Lung Cancer
Non-Small-Cell Lung Carcinoma
Squamous Cell Carcinoma of Head and Neck

Pancreatic Cancer trials near Birmingham, AL, USA:

ProAgio in Pancreatic Ductal Adenocarcinoma (PDAC)

and clinical activity of ProAgio combined with gemcitabine and nab paclitaxel (G-nP) in previously untreated subjects with metastatic pancreatic...

Enrolling
Pancreatic Ductal Carcinoma
Drug: ProAgio Dose Levels (DL) 1,2,3,4
Drug: Gemcitabine, nab paclitaxel

Phase 1

ProDa BioTech

Birmingham, Alabama, United States

A Phase I, Multicenter, Open-label, Dose-Escalation, Safety, Pharmacokinetic and Pharmacodynamic Study of Minnelide™Capsules given daily for 21 days...

Enrolling
Advanced Cancer
Breast Cancer
Drug: Minnelide™Capsules

Phase 1

Minneamrita Therapeutics

Birmingham, Alabama, United States and 6 other locations

To evaluate the efficacy of naporafenib administered with trametinib in patients with rat sarcoma viral oncogene (RAS) Q61X solid tumors* To evaluate...

Enrolling
Advanced or Metastatic Solid Tumors
Drug: Trametinib
Drug: Naporafenib

Phase 1

Erasca

Birmingham, Alabama, United States and 28 other locations

liposome injection in combination with other approved drugs used for cancer therapy, namely 5 fluorouracil/leucovorin (5FU/LV) plus oxalipla ...

Active, not recruiting
Metastatic Adenocarcinoma of the Pancreas
Drug: Leucovorin
Drug: Gemcitabine

Phase 3

Ipsen
Ipsen

Birmingham, Alabama, United States and 199 other locations

This study is about TAK-500, given either alone or with pembrolizumab, in adults with select locally advanced or metastatic solid tumors.The aims of...

Enrolling
Breast Cancer
Nasopharyngeal Cancer
Drug: TAK-500
Drug: Pembrolizumab

Phase 1, Phase 2

Takeda
Takeda

Birmingham, Alabama, United States and 11 other locations

This study is an open-label, international, multi-center, Phase 2 study in adult patients with recurrent, locally-advanced or metastatic solid tumors...

Active, not recruiting
Breast Cancer
Uterine Cancer
Drug: Seribantumab

Phase 2

Elevation Oncology

Birmingham, Alabama, United States and 41 other locations

This study will evaluate the safety, tolerability, drug levels, molecular effects, and clinical activity of MRTX849 (adagrasib) in patients with adva...

Enrolling
Metastatic Cancer
Advanced Cancer
Drug: MRTX849
Drug: Afatinib

Phase 1, Phase 2

Mirati Therapeutics
Mirati Therapeutics

Birmingham, Alabama, United States and 97 other locations

This is a Phase 1, open-label, multicenter, dose-escalation and expansion study evaluating the safety, tolerability, PK, pharmacodynamics, and clinic...

Enrolling
Endometrial Cancer
Epithelial Ovarian Cancer
Drug: Nivolumab
Drug: XB002

Phase 1

Exelixis
Exelixis

Birmingham, Alabama, United States and 91 other locations

* To evaluate the safety and tolerability of escalating doses of ERAS-007 in combination with other cancer therapies in study participants w...

Active, not recruiting
Metastatic Colorectal Cancer
Metastatic Pancreatic Ductal Adenocarcinoma
Drug: Cetuximab
Drug: ERAS-007

Phase 1, Phase 2

Erasca

Birmingham, Alabama, United States and 13 other locations

This is a first-in-human Phase 1 clinical trial designed to investigate the safety, tolerability, pharmacokinetics, and biodistribution of \[225Ac\]-...

Enrolling
Gastric Cancer
Neuroendocrine Differentiated (NED) Prostate Cancer
Drug: [225]-FPI-2059
Drug: [111In]-FPI-2058

Phase 1

Fusion Pharmaceuticals

Birmingham, Alabama, United States and 7 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems